BRPI0209720A2 - dosage and packaging of controlled release medication - Google Patents

dosage and packaging of controlled release medication

Info

Publication number
BRPI0209720A2
BRPI0209720A2 BRPI0209720A BRPI0209720A BRPI0209720A2 BR PI0209720 A2 BRPI0209720 A2 BR PI0209720A2 BR PI0209720 A BRPI0209720 A BR PI0209720A BR PI0209720 A BRPI0209720 A BR PI0209720A BR PI0209720 A2 BRPI0209720 A2 BR PI0209720A2
Authority
BR
Brazil
Prior art keywords
dosage
packaging
controlled release
release medication
medication
Prior art date
Application number
BRPI0209720A
Other languages
Portuguese (pt)
Inventor
V Gumaste Anand
L Abrams Andrew
Original Assignee
Microdose Tech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Microdose Tech Inc filed Critical Microdose Tech Inc
Publication of BRPI0209720A2 publication Critical patent/BRPI0209720A2/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J3/00—Devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
    • A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4808—Preparations in capsules, e.g. of gelatin, of chocolate characterised by the form of the capsule or the structure of the filling; Capsules containing small tablets; Capsules with outer layer for immediate drug release

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)
  • Packages (AREA)
BRPI0209720A 2001-05-31 2002-05-22 dosage and packaging of controlled release medication BRPI0209720A2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US29478601P 2001-05-31 2001-05-31
PCT/US2002/016185 WO2002096347A2 (en) 2001-05-31 2002-05-22 Metering and packaging of controlled release medication

Publications (1)

Publication Number Publication Date
BRPI0209720A2 true BRPI0209720A2 (en) 2017-06-13

Family

ID=23134944

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0209720A BRPI0209720A2 (en) 2001-05-31 2002-05-22 dosage and packaging of controlled release medication

Country Status (8)

Country Link
EP (1) EP1408907A4 (en)
JP (1) JP2005514966A (en)
AU (1) AU2002303840A1 (en)
BR (1) BRPI0209720A2 (en)
CA (3) CA2614902A1 (en)
NZ (1) NZ529696A (en)
WO (1) WO2002096347A2 (en)
ZA (1) ZA200402466B (en)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6428809B1 (en) 1999-08-18 2002-08-06 Microdose Technologies, Inc. Metering and packaging of controlled release medication
US7670612B2 (en) 2002-04-10 2010-03-02 Innercap Technologies, Inc. Multi-phase, multi-compartment capsular delivery apparatus and methods for using same
MY142179A (en) 2002-07-25 2010-10-15 Glaxo Group Ltd Multicomponent pharmaceutical dosage form
US20100260669A1 (en) * 2004-05-13 2010-10-14 Anthony Joonkyoo Yun Treatment of Seasonal Conditions Through Modulation of the Autonomic Nervous System
PT1889198E (en) 2005-04-28 2015-03-06 Proteus Digital Health Inc Pharma-informatics system
US8802183B2 (en) 2005-04-28 2014-08-12 Proteus Digital Health, Inc. Communication system with enhanced partial power source and method of manufacturing same
US8912908B2 (en) 2005-04-28 2014-12-16 Proteus Digital Health, Inc. Communication system with remote activation
JP2009511191A (en) * 2005-10-14 2009-03-19 マイクロドース・テクノロジーズ・インコーポレーテッド Orally administered drug package method
US9270025B2 (en) 2007-03-09 2016-02-23 Proteus Digital Health, Inc. In-body device having deployable antenna
US8439033B2 (en) 2007-10-09 2013-05-14 Microdose Therapeutx, Inc. Inhalation device
CA2734251A1 (en) 2008-08-13 2010-02-18 Proteus Biomedical, Inc. Ingestible circuitry
EP2424427B1 (en) 2009-04-28 2021-06-16 Otsuka Pharmaceutical Co., Ltd. Highly reliable ingestible event markers
CN105381524A (en) 2010-01-05 2016-03-09 微剂量治疗技术公司 Inhalation device and method
JP6463599B2 (en) 2010-04-07 2019-02-06 プロテウス デジタル ヘルス， インコーポレイテッド Small ingestible device
JP2014504902A (en) 2010-11-22 2014-02-27 プロテウス デジタル ヘルス， インコーポレイテッド Ingestible device with medicinal product
WO2015112603A1 (en) 2014-01-21 2015-07-30 Proteus Digital Health, Inc. Masticable ingestible product and communication system therefor
US9756874B2 (en) 2011-07-11 2017-09-12 Proteus Digital Health, Inc. Masticable ingestible product and communication system therefor
CA2897198A1 (en) 2012-07-23 2014-01-30 Proteus Digital Health, Inc. Techniques for manufacturing ingestible event markers comprising an ingestible component
BR112015008434A2 (en) 2012-10-18 2017-07-04 Proteus Digital Health Inc apparatus, system and method for adaptively optimizing power dissipation and broadcasting power at a power source for a communication device
JP2016508529A (en) 2013-01-29 2016-03-22 プロテウス デジタル ヘルス， インコーポレイテッド Highly expandable polymer film and composition containing the same
US10175376B2 (en) 2013-03-15 2019-01-08 Proteus Digital Health, Inc. Metal detector apparatus, system, and method
US9796576B2 (en) 2013-08-30 2017-10-24 Proteus Digital Health, Inc. Container with electronically controlled interlock
US10084880B2 (en) 2013-11-04 2018-09-25 Proteus Digital Health, Inc. Social media networking based on physiologic information
US11051543B2 (en) 2015-07-21 2021-07-06 Otsuka Pharmaceutical Co. Ltd. Alginate on adhesive bilayer laminate film
JP6552148B1 (en) 2016-07-22 2019-07-31 プロテウス デジタル ヘルス， インコーポレイテッド Electromagnetic sensing and detection of ingestible event markers
US10820831B2 (en) 2016-10-26 2020-11-03 Proteus Digital Health, Inc. Methods for manufacturing capsules with ingestible event markers

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4808413A (en) * 1987-04-28 1989-02-28 E. R. Squibb & Sons, Inc. Pharmaceutical compositions in the form of beadlets and method
US4795644A (en) * 1987-08-03 1989-01-03 Merck & Co., Inc. Device for pH independent release of drugs through the Donnan-like influence of charged insoluble resins
US5714007A (en) 1995-06-06 1998-02-03 David Sarnoff Research Center, Inc. Apparatus for electrostatically depositing a medicament powder upon predefined regions of a substrate
US5699649A (en) 1996-07-02 1997-12-23 Abrams; Andrew L. Metering and packaging device for dry powders
FR2771010B1 (en) * 1997-11-19 2003-08-15 Adir USE OF A COMBINATION OF AN ANGIOTENSIN CONVERSION ENZYME INHIBITOR AND A DIURETIC FOR THE TREATMENT OF MICROCIRCULATORY DISORDERS
US5960609A (en) * 1998-06-12 1999-10-05 Microdose Technologies, Inc. Metering and packaging method and device for pharmaceuticals and drugs
US6428809B1 (en) * 1999-08-18 2002-08-06 Microdose Technologies, Inc. Metering and packaging of controlled release medication

Also Published As

Publication number Publication date
CA2614899A1 (en) 2002-12-05
CA2448997A1 (en) 2002-12-05
NZ529696A (en) 2008-07-31
EP1408907A2 (en) 2004-04-21
AU2002303840A1 (en) 2002-12-09
EP1408907A4 (en) 2010-02-24
WO2002096347A3 (en) 2003-03-27
ZA200402466B (en) 2006-07-26
JP2005514966A (en) 2005-05-26
WO2002096347A2 (en) 2002-12-05
CA2614902A1 (en) 2002-12-05

Similar Documents

Publication Publication Date Title
BRPI0209720A2 (en) dosage and packaging of controlled release medication
HK1070285A1 (en) Pharmaceutical dosage form of amorphous nelfinavirmesylate
DE60115418D1 (en) MICROINFUSION DEVICE FOR THE ADMINISTRATION OF MEDICAMENTS
NO20030627L (en) Hydrogel-driven drug dosage form
NO20022970L (en) Hydrogel-driven drug dosage form
DE60126321D1 (en) GELSYSTEM FOR THE OCULAR ADMINISTRATION OF MEDICINAL PRODUCTS
NO20033384D0 (en) Pharmaceutical formulation
GB0117618D0 (en) Pharmaceutical dosage form
ATE307571T1 (en) PHARMACEUTICAL FORMULATION CONTAINING BICALUTAMID
FI4823U1 (en) Modified release drug formulation
DE60225014D1 (en) PHARMACEUTICAL COMPOSITIONS OF AMLODIPIN AND ATORVASTATIN
ECSP045171A (en) DOSAGE REGIME AND PHARMACEUTICAL COMPOSITION FOR EMERGENCY ANTI-CONCEPT
NO20035627D0 (en) Pharmaceutical formulation
GB0117619D0 (en) Pharmaceutical dosage form
ATE324883T1 (en) PHARMACEUTICAL COMPOSITION CONTAINING LUMIRACOXIB
FI20000780A (en) Oral dosage form for controlled release of the drug
DE60203537D1 (en) 5HT1-RECEPTORAGONIST-CONTAINING MEDICAMENT
ATE350016T1 (en) PHARMACEUTICAL COMPOSITION CONTAINING BICALUTAMID
ITBO20010005V0 (en) AUTOMATIC DISPENSER OF MEDICINAL PRODUCTS
ATE350029T1 (en) PHARMACEUTICAL COMPOSITION CONTAINING GAMMA-BUTYROBETAIN
DE60214533D1 (en) PYRIDOINDOLON DERIVATIVES AND ANTIBODIES CONTAINING PHARMACEUTICAL MIXTURES
UA4167S (en) SET OF PACKAGING FOR METROZOL DRUGS
UA6050S (en) PACKAGING OF THE MEDICAL PREPARATION
UA6049S (en) PACKAGING OF THE MEDICAL PREPARATION
UA4854S (en) PACKAGING OF THE MEDICAL PREPARATION

Legal Events

Date Code Title Description
B07D Technical examination (opinion) related to article 229 of industrial property law
B08F Application fees: dismissal - article 86 of industrial property law
B07E Notice of approval relating to section 229 industrial property law

Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI